PETROLATUM

PETROLATUM was reported 1451 times

PETROLATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LARGE CELL LUNG CANCER METASTATIC 2 0.1176
1 PNEUMONIA LIPOID 7 0.0511
2 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING BY CHILD 1 0.0476
3 EYELID EROSION 2 0.0230
4 ALVEOLAR RHABDOMYOSARCOMA 1 0.0227
5 DUODENAL NEOPLASM 2 0.0204
6 EXPOSURE VIA INHALATION 4 0.0185
7 ANAL EROSION 2 0.0182
8 ACANTHOLYSIS 1 0.0152
9 GASTROSTOMY TUBE SITE COMPLICATION 3 0.0150
10 MUCOCUTANEOUS RASH 2 0.0130
11 ACQUIRED HYDROCELE 1 0.0120
12 AMOEBIC COLITIS 1 0.0110
13 NEUROBLASTOMA 4 0.0104
14 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
15 ILIUM FRACTURE 2 0.0098
16 ZINC DEFICIENCY 2 0.0093
17 ECZEMA HERPETICUM 4 0.0086
18 URETHRAL DISORDER 4 0.0085
19 ADRENAL SUPPRESSION 6 0.0071
20 ERYTHEMA ANNULARE 2 0.0069
21 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
22 UPPER RESPIRATORY TRACT INFLAMMATION 7 0.0058
23 SEPTIC ARTHRITIS STAPHYLOCOCCAL 2 0.0057
24 LIP EROSION 4 0.0055
25 LICHENIFICATION 2 0.0049
26 VERTEBRAL OSTEOPHYTE 2 0.0047
27 CANDIDA SEPSIS 4 0.0045
28 FEEDING INTOLERANCE 2 0.0044
29 BIOPSY BONE MARROW 2 0.0043
30 ECZEMA ASTEATOTIC 2 0.0042
31 HYPOCHROMIC ANAEMIA 4 0.0039
32 ADENOIDAL DISORDER 1 0.0038
33 OCCULT BLOOD 2 0.0038
34 SEPTIC EMBOLUS 3 0.0036
35 BODY TINEA 2 0.0036
36 ENANTHEMA 2 0.0035
37 ENTEROVIRUS INFECTION 3 0.0035
38 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
39 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
40 BLOOD UREA DECREASED 4 0.0032
41 CHONDROCALCINOSIS 2 0.0031
42 SKIN EROSION 9 0.0028
43 INFANTILE SPASMS 2 0.0028
44 VITAMIN B COMPLEX DEFICIENCY 2 0.0027
45 ANASTOMOTIC STENOSIS 1 0.0027
46 IMPETIGO 4 0.0027
47 STEROID DIABETES 4 0.0027
48 TRACHEITIS 2 0.0026
49 PULMONARY ARTERY THROMBOSIS 2 0.0026
50 PSEUDOMONAS TEST POSITIVE 2 0.0024
51 APPLICATION SITE LACERATION 1 0.0024
52 INSULIN RESISTANCE 5 0.0024
53 ANXIETY DISORDER 8 0.0024
54 ANAEMIA OF CHRONIC DISEASE 2 0.0022
55 ANASTOMOTIC ULCER 1 0.0022
56 KLEBSIELLA BACTERAEMIA 2 0.0021
57 BLOOD URINE 2 0.0021
58 CONJUNCTIVITIS ALLERGIC 3 0.0020
59 CHOLANGIOCARCINOMA 3 0.0020
60 IMMUNE-MEDIATED DERMATITIS 2 0.0020
61 ILEAL ULCER 2 0.0020
62 MARASMUS 3 0.0020
63 CORONAVIRUS TEST POSITIVE 2 0.0019
64 MONOCYTE COUNT INCREASED 7 0.0019
65 HYPOPERFUSION 2 0.0019
66 OVARIAN CANCER RECURRENT 3 0.0019
67 METASTATIC NEOPLASM 8 0.0019
68 PELVIC ABSCESS 2 0.0017
69 PULMONARY TOXICITY 12 0.0017
70 PUSTULE 4 0.0017
71 PNEUMONIA INFLUENZAL 2 0.0017
72 OTITIS EXTERNA 2 0.0016
73 VESTIBULAR DISORDER 2 0.0016
74 ORAL MUCOSA EROSION 2 0.0016
75 RHINITIS ALLERGIC 7 0.0016
76 CANCER PAIN 4 0.0016
77 PLATELET TRANSFUSION 2 0.0016
78 APPLICATION SITE EROSION 2 0.0016
79 ABDOMINAL WALL ABSCESS 1 0.0015
80 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
81 RHINOVIRUS INFECTION 6 0.0015
82 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
83 GASTROENTERITIS NOROVIRUS 2 0.0015
84 DERMATITIS ACNEIFORM 9 0.0015
85 EYELID PAIN 3 0.0015
86 CHOLANGITIS SCLEROSING 3 0.0015
87 AORTITIS 1 0.0015
88 INFUSION SITE RASH 2 0.0015
89 BEZOAR 2 0.0014
90 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
91 SUDDEN ONSET OF SLEEP 2 0.0014
92 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
93 SKIN INFECTION 16 0.0014
94 IRON DEFICIENCY ANAEMIA 13 0.0014
95 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
96 SPUTUM INCREASED 3 0.0014
97 PERIODONTITIS 3 0.0014
98 NODAL RHYTHM 2 0.0014
99 PSEUDOMEMBRANOUS COLITIS 3 0.0013
100 AORTIC DISORDER 1 0.0013
101 TINEA PEDIS 2 0.0013
102 OPTIC NERVE DISORDER 2 0.0012
103 COLON CANCER METASTATIC 2 0.0012
104 DECUBITUS ULCER 10 0.0012
105 SEBORRHOEIC DERMATITIS 2 0.0012
106 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
107 PNEUMONIA BACTERIAL 11 0.0012
108 MALIGNANT PLEURAL EFFUSION 2 0.0012
109 EROSIVE OESOPHAGITIS 2 0.0012
110 BACTERAEMIA 14 0.0012
111 ACUTE SINUSITIS 2 0.0012
112 SCHIZOPHRENIA 14 0.0012
113 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
114 INFUSION SITE DISCHARGE 2 0.0011
115 PARONYCHIA 5 0.0011
116 BRONCHIOLITIS 4 0.0011
117 SKIN WEEPING 4 0.0011
118 UTERINE POLYP 2 0.0011
119 ESSENTIAL HYPERTENSION 2 0.0011
120 SINUS NODE DYSFUNCTION 2 0.0011
121 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
122 ADENOCARCINOMA OF COLON 2 0.0011
123 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
124 PEMPHIGOID 8 0.0011
125 CATHETER SITE INFECTION 4 0.0011
126 BONE MARROW TRANSPLANT 2 0.0011
127 PNEUMATOSIS INTESTINALIS 3 0.0011
128 ACTINOMYCOSIS 1 0.0010
129 ENTEROCOLITIS 6 0.0010
130 ARTERIAL THROMBOSIS 2 0.0010
131 HAEMOTHORAX 3 0.0010
132 ANTIBIOTIC THERAPY 1 0.0010
133 IMMUNE-MEDIATED HEPATIC DISORDER 2 0.0010
134 VITAMIN D DEFICIENCY 10 0.0010
135 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
136 CONCOMITANT DISEASE PROGRESSION 2 0.0010
137 HEPATITIS FULMINANT 3 0.0010
138 BLEPHARITIS 4 0.0010
139 IMMUNE-MEDIATED HEPATITIS 2 0.0010
140 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
141 HYPERURICAEMIA 4 0.0010
142 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
143 PORTAL HYPERTENSION 3 0.0010
144 SPINAL COMPRESSION FRACTURE 8 0.0010
145 BLOOD BILIRUBIN INCREASED 26 0.0010
146 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
147 NEUROGENIC BLADDER 2 0.0009
148 HORDEOLUM 4 0.0009
149 DIABETIC NEPHROPATHY 2 0.0009
150 OTITIS MEDIA 3 0.0009
151 ADRENAL INSUFFICIENCY 11 0.0009
152 AORTIC DILATATION 1 0.0009
153 LARGE INTESTINAL OBSTRUCTION 2 0.0009
154 APPLICATION SITE URTICARIA 2 0.0009
155 PNEUMONIA ASPIRATION 22 0.0009
156 PRIAPISM 3 0.0009
157 AORTIC THROMBOSIS 1 0.0009
158 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
159 CELLULITIS 43 0.0009
160 DRUG ERUPTION 15 0.0008
161 PULMONARY INFARCTION 2 0.0008
162 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
163 ACUTE LUNG INJURY 1 0.0008
164 FIBRIN D DIMER INCREASED 3 0.0008
165 SINUS OPERATION 2 0.0008
166 ACCIDENT 10 0.0008
167 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
168 DERMAL CYST 2 0.0008
169 HYPOPHOSPHATAEMIA 6 0.0008
170 STEVENS-JOHNSON SYNDROME 18 0.0008
171 HYPERVOLAEMIA 4 0.0008
172 PYELONEPHRITIS 7 0.0008
173 LEUKOENCEPHALOPATHY 3 0.0008
174 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
175 CATHETER SITE HAEMORRHAGE 2 0.0008
176 EYELID IRRITATION 2 0.0008
177 URINARY TRACT INFECTION BACTERIAL 2 0.0008
178 GINGIVAL DISORDER 3 0.0008
179 MEAN CELL VOLUME INCREASED 2 0.0008
180 HEPATOSPLENOMEGALY 2 0.0008
181 PHYSICAL DECONDITIONING 2 0.0008
182 DRUG TITRATION ERROR 2 0.0008
183 ADJUSTMENT DISORDER 1 0.0008
184 ANAEMIA POSTOPERATIVE 1 0.0008
185 PNEUMONIA FUNGAL 3 0.0008
186 SERUM FERRITIN INCREASED 4 0.0008
187 ACROCHORDON 1 0.0008
188 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
189 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
190 LIP BLISTER 2 0.0007
191 BLOOD PHOSPHORUS INCREASED 2 0.0007
192 AGORAPHOBIA 1 0.0007
193 ABSCESS ORAL 1 0.0007
194 ILEUS 9 0.0007
195 GASTRIC ULCER HAEMORRHAGE 4 0.0007
196 ANAL HAEMORRHAGE 2 0.0007
197 SKIN HYPERTROPHY 2 0.0007
198 PURULENT DISCHARGE 3 0.0007
199 PULMONARY TUBERCULOSIS 3 0.0007
200 LIP PAIN 2 0.0007
201 BLOOD URIC ACID INCREASED 4 0.0007
202 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
203 ADENOVIRUS INFECTION 2 0.0007
204 FEBRILE NEUTROPENIA 45 0.0007
205 COVID-19 PNEUMONIA 8 0.0007
206 ILEUS PARALYTIC 3 0.0007
207 HYDRONEPHROSIS 5 0.0007
208 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
209 SKIN FISSURES 13 0.0007
210 GANGRENE 4 0.0007
211 DELIRIUM 23 0.0007
212 MYELOFIBROSIS 2 0.0007
213 VASCULAR DEVICE INFECTION 3 0.0007
214 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
215 KERATITIS 2 0.0007
216 PIGMENTATION DISORDER 4 0.0006
217 CHOLANGITIS 4 0.0006
218 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
219 ERYTHEMA MULTIFORME 6 0.0006
220 HEPATIC FUNCTION ABNORMAL 24 0.0006
221 INFUSION SITE PRURITUS 2 0.0006
222 NON-SMALL CELL LUNG CANCER 3 0.0006
223 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
224 APHAGIA 3 0.0006
225 ENTEROCOCCAL INFECTION 3 0.0006
226 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
227 BACTERIAL SEPSIS 2 0.0006
228 HEPATOMEGALY 6 0.0006
229 APPLICATION SITE BURN 3 0.0006
230 HYPOGAMMAGLOBULINAEMIA 4 0.0006
231 INJECTION SITE INFECTION 2 0.0006
232 DEAFNESS NEUROSENSORY 2 0.0006
233 ANTIBODY TEST POSITIVE 1 0.0006
234 ELECTROLYTE IMBALANCE 7 0.0006
235 CARDIAC FAILURE ACUTE 4 0.0006
236 CORONARY ARTERY STENOSIS 3 0.0006
237 METASTASES TO SPINE 2 0.0006
238 DYSLIPIDAEMIA 3 0.0006
239 HEPATIC CYST 2 0.0006
240 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
241 ACUTE RESPIRATORY FAILURE 11 0.0006
242 DUODENAL ULCER 4 0.0006
243 JAUNDICE CHOLESTATIC 2 0.0006
244 HAEMORRHOIDS 11 0.0006
245 HAEMORRHAGIC DIATHESIS 2 0.0006
246 RETINAL HAEMORRHAGE 4 0.0006
247 CONJUNCTIVAL HYPERAEMIA 2 0.0006
248 GINGIVITIS 3 0.0006
249 PYODERMA GANGRENOSUM 2 0.0006
250 ERYTHEMA OF EYELID 3 0.0006
251 DERMATITIS BULLOUS 4 0.0006
252 OESOPHAGITIS 6 0.0005
253 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
254 NEUTROPHIL COUNT DECREASED 22 0.0005
255 URINARY RETENTION 18 0.0005
256 DERMATITIS ATOPIC 28 0.0005
257 PERONEAL NERVE PALSY 3 0.0005
258 DERMATITIS CONTACT 6 0.0005
259 SCAB 6 0.0005
260 DERMATITIS 11 0.0005
261 CARDIAC VALVE DISEASE 3 0.0005
262 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
263 SPINAL CORD COMPRESSION 2 0.0005
264 WOUND SECRETION 2 0.0005
265 PLEURISY 3 0.0005
266 BLOOD ALBUMIN DECREASED 4 0.0005
267 RENAL CYST 4 0.0005
268 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
269 AZOTAEMIA 2 0.0005
270 APPLICATION SITE PAIN 11 0.0005
271 SKIN PAPILLOMA 2 0.0005
272 CYSTITIS HAEMORRHAGIC 2 0.0005
273 C-REACTIVE PROTEIN INCREASED 18 0.0005
274 RECURRENT CANCER 2 0.0005
275 PERIPHERAL ISCHAEMIA 2 0.0005
276 ARTHRITIS BACTERIAL 2 0.0005
277 SELF-MEDICATION 2 0.0005
278 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
279 HYPERCALCAEMIA 6 0.0005
280 CONJUNCTIVITIS 9 0.0005
281 PHARYNGITIS 6 0.0005
282 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
283 SEPTIC SHOCK 21 0.0005
284 GASTROINTESTINAL PERFORATION 2 0.0005
285 SECOND PRIMARY MALIGNANCY 4 0.0005
286 PLEURAL EFFUSION 29 0.0005
287 ONYCHOMADESIS 2 0.0005
288 INTERSTITIAL LUNG DISEASE 23 0.0005
289 SCRATCH 5 0.0005
290 AORTIC VALVE INCOMPETENCE 2 0.0005
291 ENTERITIS 3 0.0005
292 VITAMIN D DECREASED 4 0.0005
293 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
294 ANURIA 4 0.0005
295 APPLICATION SITE SCAB 1 0.0005
296 OCULAR ICTERUS 2 0.0005
297 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
298 PLATELET COUNT INCREASED 6 0.0005
299 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
300 PULMONARY FUNCTION TEST DECREASED 2 0.0005
301 TUMOUR LYSIS SYNDROME 4 0.0005
302 PURPURA 4 0.0005
303 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
304 POST-TRAUMATIC STRESS DISORDER 3 0.0004
305 MALNUTRITION 5 0.0004
306 ADENOCARCINOMA 1 0.0004
307 PAPILLOEDEMA 2 0.0004
308 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
309 PNEUMOTHORAX 7 0.0004
310 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
311 ABNORMAL LOSS OF WEIGHT 3 0.0004
312 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
313 ISCHAEMIA 2 0.0004
314 APHTHOUS STOMATITIS 1 0.0004
315 PERICARDIAL EFFUSION 10 0.0004
316 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
317 ROSACEA 2 0.0004
318 SKIN TIGHTNESS 2 0.0004
319 VAGINAL INFECTION 2 0.0004
320 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
321 VISUAL FIELD DEFECT 3 0.0004
322 ATELECTASIS 4 0.0004
323 HYPOTHYROIDISM 13 0.0004
324 BREATH SOUNDS ABNORMAL 2 0.0004
325 STAPHYLOCOCCAL SEPSIS 2 0.0004
326 LIGAMENT SPRAIN 4 0.0004
327 ACUTE PSYCHOSIS 1 0.0004
328 FOOT OPERATION 2 0.0004
329 DIABETIC NEUROPATHY 2 0.0004
330 ORGANISING PNEUMONIA 2 0.0004
331 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
332 APPLICATION SITE SWELLING 2 0.0004
333 HYPERAMMONAEMIA 2 0.0004
334 FLUID INTAKE REDUCED 2 0.0004
335 EMPHYSEMA 4 0.0004
336 DYSPHORIA 2 0.0004
337 TOXIC ENCEPHALOPATHY 2 0.0004
338 ACIDOSIS 3 0.0004
339 AMMONIA INCREASED 2 0.0004
340 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
341 CACHEXIA 2 0.0004
342 AORTIC ARTERIOSCLEROSIS 1 0.0004
343 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
344 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
345 CARDIAC FAILURE 31 0.0004
346 HYPOALBUMINAEMIA 3 0.0004
347 FAILURE TO THRIVE 2 0.0004
348 ACUTE MYELOID LEUKAEMIA 6 0.0004
349 HYPERGLYCAEMIA 14 0.0004
350 ANGINA PECTORIS 11 0.0004
351 ECZEMA 20 0.0004
352 OBESITY 6 0.0004
353 ATRIAL FLUTTER 3 0.0004
354 ANIMAL BITE 1 0.0004
355 ALCOHOL ABUSE 1 0.0004
356 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
357 ANAL FISSURE 2 0.0004
358 BLOOD SODIUM DECREASED 7 0.0004
359 CHEILITIS 2 0.0004
360 HYPOXIA 13 0.0004
361 HYPOKALAEMIA 17 0.0004
362 APPLICATION SITE HAEMORRHAGE 1 0.0004
363 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
364 ESCHERICHIA INFECTION 3 0.0004
365 MELAENA 8 0.0004
366 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
367 DENTAL CARIES 4 0.0004
368 BLOOD UREA INCREASED 6 0.0004
369 MACULAR OEDEMA 2 0.0004
370 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
371 BLOOD MAGNESIUM DECREASED 3 0.0003
372 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
373 RALES 2 0.0003
374 GASTROENTERITIS 5 0.0003
375 SEPSIS 38 0.0003
376 DECREASED INTEREST 2 0.0003
377 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
378 PULMONARY HYPERTENSION 7 0.0003
379 SYMPTOM RECURRENCE 2 0.0003
380 LIP DRY 3 0.0003
381 DEVICE RELATED INFECTION 5 0.0003
382 OLIGURIA 2 0.0003
383 SKIN EXFOLIATION 27 0.0003
384 SECRETION DISCHARGE 4 0.0003
385 SWELLING OF EYELID 2 0.0003
386 PRODUCT USE COMPLAINT 5 0.0003
387 PHOTOPSIA 2 0.0003
388 CHOLESTASIS 6 0.0003
389 PLATELET COUNT DECREASED 33 0.0003
390 APPLICATION SITE VESICLES 2 0.0003
391 METASTASES TO BONE 5 0.0003
392 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
393 HYPONATRAEMIA 17 0.0003
394 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
395 TOXIC SKIN ERUPTION 3 0.0003
396 BRONCHIECTASIS 2 0.0003
397 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
398 PRODUCT LABEL ISSUE 2 0.0003
399 TOOTH ABSCESS 3 0.0003
400 APPLICATION SITE DRYNESS 1 0.0003
401 NEUTROPHIL COUNT INCREASED 3 0.0003
402 LUNG NEOPLASM MALIGNANT 12 0.0003
403 NEPHROTIC SYNDROME 2 0.0003
404 ONYCHOCLASIS 2 0.0003
405 VENTRICULAR EXTRASYSTOLES 3 0.0003
406 LARGE INTESTINE POLYP 2 0.0003
407 RESPIRATORY FAILURE 21 0.0003
408 TENDERNESS 3 0.0003
409 AUTOIMMUNE HEPATITIS 2 0.0003
410 HYPOMAGNESAEMIA 4 0.0003
411 PRODUCT ODOUR ABNORMAL 3 0.0003
412 RIGHT VENTRICULAR FAILURE 2 0.0003
413 INJECTION SITE DISCOMFORT 3 0.0003
414 BLISTER 16 0.0003
415 PAPULE 2 0.0003
416 LYMPHOCYTE COUNT DECREASED 5 0.0003
417 SEASONAL ALLERGY 4 0.0003
418 THERMAL BURN 2 0.0003
419 DIVERTICULUM 2 0.0003
420 APPENDICECTOMY 1 0.0003
421 NEUTROPENIC SEPSIS 2 0.0003
422 GRAFT VERSUS HOST DISEASE 2 0.0003
423 MYELODYSPLASTIC SYNDROME 4 0.0003
424 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
425 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
426 ASCITES 8 0.0003
427 AMYLASE INCREASED 1 0.0003
428 VENTRICULAR FIBRILLATION 3 0.0003
429 ARTHROPOD BITE 2 0.0003
430 RESPIRATORY TRACT INFECTION 7 0.0003
431 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
432 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
433 PYREXIA 92 0.0003
434 HYPOCALCAEMIA 5 0.0003
435 FOOT FRACTURE 5 0.0003
436 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
437 DEHYDRATION 35 0.0003
438 DRY SKIN 35 0.0003
439 SLEEP APNOEA SYNDROME 5 0.0003
440 RENAL IMPAIRMENT 22 0.0003
441 GASTRIC HAEMORRHAGE 3 0.0003
442 METASTASES TO LUNG 3 0.0003
443 HAEMOLYSIS 2 0.0003
444 VASCULITIS 3 0.0003
445 ANAEMIA 49 0.0003
446 BRONCHITIS 19 0.0003
447 HYPERKALAEMIA 9 0.0003
448 PULMONARY HAEMORRHAGE 2 0.0003
449 DRUG-INDUCED LIVER INJURY 8 0.0003
450 SINUS DISORDER 5 0.0003
451 FURUNCLE 2 0.0003
452 URINARY TRACT INFECTION 43 0.0003
453 ULCER 4 0.0003
454 CEREBRAL HAEMORRHAGE 9 0.0003
455 HYPERLIPIDAEMIA 3 0.0003
456 RHINITIS 2 0.0002
457 STENT PLACEMENT 2 0.0002
458 STOMATITIS 15 0.0002
459 FEEDING DISORDER 5 0.0002
460 BLOOD POTASSIUM INCREASED 4 0.0002
461 APPLICATION SITE DISCOLOURATION 1 0.0002
462 SHOCK HAEMORRHAGIC 2 0.0002
463 CARDIOMEGALY 3 0.0002
464 HICCUPS 2 0.0002
465 APPLICATION SITE EXFOLIATION 1 0.0002
466 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
467 STAPHYLOCOCCAL INFECTION 8 0.0002
468 EMBOLISM 2 0.0002
469 HEMIPLEGIA 2 0.0002
470 ACCIDENTAL EXPOSURE 1 0.0002
471 SKIN DISORDER 8 0.0002
472 COLITIS 9 0.0002
473 INFUSION SITE ERYTHEMA 2 0.0002
474 GASTRIC CANCER 6 0.0002
475 RESPIRATORY DISORDER 7 0.0002
476 PRODUCT CONTAINER ISSUE 2 0.0002
477 PSEUDOMONAS INFECTION 2 0.0002
478 LIVER FUNCTION TEST INCREASED 5 0.0002
479 INJECTION SITE INDURATION 3 0.0002
480 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
481 FAECES DISCOLOURED 5 0.0002
482 URINE OUTPUT DECREASED 2 0.0002
483 NAIL DISORDER 2 0.0002
484 GASTRITIS 6 0.0002
485 SPINAL OSTEOARTHRITIS 2 0.0002
486 TOOTH INFECTION 3 0.0002
487 GRIP STRENGTH DECREASED 2 0.0002
488 IMMUNOSUPPRESSION 2 0.0002
489 LUNG INFILTRATION 2 0.0002
490 ABDOMINAL ABSCESS 1 0.0002
491 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
492 FEMUR FRACTURE 7 0.0002
493 LIVER DISORDER 10 0.0002
494 PNEUMONIA 73 0.0002
495 RASH MACULO-PAPULAR 5 0.0002
496 HEPATOTOXICITY 5 0.0002
497 HAEMOLYTIC ANAEMIA 2 0.0002
498 HAEMARTHROSIS 2 0.0002
499 GOUT 4 0.0002
500 OROPHARYNGEAL DISCOMFORT 2 0.0002
501 LEUKOCYTOSIS 4 0.0002
502 TACHYPNOEA 3 0.0002
503 ACUTE HEPATIC FAILURE 3 0.0002
504 EXOSTOSIS 2 0.0002
505 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
506 OVARIAN CANCER 2 0.0002
507 MENTAL STATUS CHANGES 6 0.0002
508 ORAL DISCOMFORT 3 0.0002
509 HAEMOPTYSIS 6 0.0002
510 WOUND 6 0.0002
511 HAEMOGLOBIN DECREASED 22 0.0002
512 DEFORMITY 2 0.0002
513 SQUAMOUS CELL CARCINOMA 2 0.0002
514 PAIN IN JAW 6 0.0002
515 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
516 INFUSION RELATED REACTION 14 0.0002
517 SPUTUM DISCOLOURED 2 0.0002
518 EYE INFLAMMATION 2 0.0002
519 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
520 PULMONARY FIBROSIS 4 0.0002
521 EYE PRURITUS 7 0.0002
522 GLAUCOMA 4 0.0002
523 HYPERCHOLESTEROLAEMIA 2 0.0002
524 CONSTIPATION 45 0.0002
525 HYPOGLYCAEMIA 10 0.0002
526 CEREBRAL INFARCTION 5 0.0002
527 HAEMATURIA 7 0.0002
528 RASH 89 0.0002
529 VITREOUS FLOATERS 2 0.0002
530 OEDEMA 11 0.0002
531 HOSPICE CARE 2 0.0002
532 SKIN HAEMORRHAGE 3 0.0002
533 BLADDER DISORDER 2 0.0002
534 PULMONARY MASS 3 0.0002
535 ABDOMINAL TENDERNESS 1 0.0002
536 PULMONARY OEDEMA 9 0.0002
537 EPISTAXIS 15 0.0002
538 OVARIAN CYST 2 0.0002
539 NEUROPATHY PERIPHERAL 19 0.0002
540 ERYTHEMA 41 0.0002
541 CYTOKINE RELEASE SYNDROME 4 0.0002
542 HAEMATOCHEZIA 11 0.0002
543 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
544 HYPOTHERMIA 2 0.0002
545 TASTE DISORDER 4 0.0002
546 OEDEMA PERIPHERAL 24 0.0002
547 PANCYTOPENIA 11 0.0002
548 SUBARACHNOID HAEMORRHAGE 2 0.0002
549 HYPOPHAGIA 5 0.0002
550 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
551 MUSCULOSKELETAL CHEST PAIN 3 0.0002
552 RASH GENERALISED 5 0.0002
553 HYPERBILIRUBINAEMIA 2 0.0002
554 EYE DISCHARGE 2 0.0002
555 MUSCULOSKELETAL PAIN 10 0.0002
556 APPLICATION SITE ERYTHEMA 5 0.0002
557 DECREASED APPETITE 44 0.0002
558 RESPIRATORY TRACT CONGESTION 3 0.0002
559 CYSTITIS 6 0.0002
560 RASH ERYTHEMATOUS 9 0.0002
561 METABOLIC ACIDOSIS 6 0.0002
562 PAIN OF SKIN 5 0.0002
563 CATARACT 11 0.0002
564 DEEP VEIN THROMBOSIS 12 0.0002
565 PNEUMONITIS 5 0.0002
566 DYSPEPSIA 18 0.0002
567 WOUND INFECTION 2 0.0002
568 GASTROINTESTINAL PAIN 2 0.0002
569 VENTRICULAR TACHYCARDIA 3 0.0002
570 TACHYCARDIA 16 0.0002
571 FUNGAL INFECTION 6 0.0002
572 TRANSAMINASES INCREASED 4 0.0002
573 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
574 PERICARDITIS 3 0.0002
575 TYPE 2 DIABETES MELLITUS 6 0.0002
576 OCULAR DISCOMFORT 2 0.0002
577 PANCREATITIS ACUTE 4 0.0002
578 FACE OEDEMA 3 0.0002
579 CANDIDA INFECTION 3 0.0002
580 EYE PAIN 10 0.0002
581 MITRAL VALVE INCOMPETENCE 2 0.0002
582 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
583 INTERNAL HAEMORRHAGE 2 0.0002
584 MYOCARDITIS 2 0.0002
585 SHOCK 4 0.0002
586 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
587 EYELID OEDEMA 2 0.0002
588 SPLENOMEGALY 2 0.0002
589 SPINAL PAIN 2 0.0002
590 METASTASES TO LIVER 3 0.0002
591 COLD SWEAT 3 0.0002
592 NASAL CONGESTION 10 0.0002
593 ACUTE KIDNEY INJURY 26 0.0002
594 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
595 BRADYCARDIA 9 0.0002
596 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
597 ACUTE MYOCARDIAL INFARCTION 5 0.0002
598 BLOOD CREATININE INCREASED 11 0.0002
599 CHOLECYSTITIS 2 0.0002
600 BLOOD POTASSIUM DECREASED 5 0.0002
601 TOOTHACHE 3 0.0002
602 HEPATITIS C 2 0.0002
603 BLOOD PRESSURE DECREASED 11 0.0002
604 BONE DISORDER 3 0.0002
605 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
606 PRURITUS 63 0.0002
607 RESPIRATORY DEPRESSION 2 0.0002
608 INJECTION SITE EXTRAVASATION 2 0.0002
609 GENERALISED OEDEMA 2 0.0002
610 EYE SWELLING 6 0.0002
611 BACTERIAL INFECTION 3 0.0002
612 APPLICATION SITE IRRITATION 2 0.0002
613 DRY EYE 8 0.0002
614 OXYGEN SATURATION DECREASED 9 0.0002
615 PEMPHIGUS 2 0.0002
616 PHOTOPHOBIA 3 0.0002
617 DYSARTHRIA 6 0.0002
618 DYSPNOEA EXERTIONAL 6 0.0002
619 INTESTINAL OBSTRUCTION 6 0.0002
620 BRAIN OEDEMA 2 0.0002
621 RENAL FAILURE 21 0.0002
622 GASTRIC ULCER 3 0.0002
623 POST PROCEDURAL COMPLICATION 3 0.0002
624 INFUSION SITE PAIN 2 0.0002
625 ANOREXIA 2 0.0002
626 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
627 ORAL HERPES 3 0.0002
628 IMPAIRED HEALING 5 0.0002
629 OSTEONECROSIS 5 0.0002
630 ORAL CANDIDIASIS 2 0.0002
631 PULMONARY CONGESTION 2 0.0002
632 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
633 ADVERSE REACTION 2 0.0002
634 EXPIRED PRODUCT ADMINISTERED 5 0.0002
635 EAR INFECTION 4 0.0002
636 VIRAL INFECTION 5 0.0002
637 LIP SWELLING 5 0.0001
638 MUSCULAR WEAKNESS 17 0.0001
639 SINUS CONGESTION 2 0.0001
640 BONE MARROW FAILURE 3 0.0001
641 FEELING HOT 9 0.0001
642 NASOPHARYNGITIS 27 0.0001
643 CORONARY ARTERY OCCLUSION 2 0.0001
644 RESPIRATORY DISTRESS 4 0.0001
645 DIABETES MELLITUS 11 0.0001
646 APHONIA 2 0.0001
647 MASS 2 0.0001
648 OSTEOARTHRITIS 6 0.0001
649 LYMPHOPENIA 2 0.0001
650 LYMPHADENOPATHY 5 0.0001
651 SINUS TACHYCARDIA 2 0.0001
652 JOINT INJURY 3 0.0001
653 LEUKOPENIA 7 0.0001
654 RED BLOOD CELL COUNT DECREASED 4 0.0001
655 RECTAL HAEMORRHAGE 6 0.0001
656 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
657 HYPERSOMNIA 4 0.0001
658 CARDIOGENIC SHOCK 2 0.0001
659 SKIN CANCER 3 0.0001
660 MYELOSUPPRESSION 5 0.0001
661 HYPOKINESIA 2 0.0001
662 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
663 FLUID OVERLOAD 2 0.0001
664 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
665 DYSURIA 5 0.0001
666 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
667 CARDIOMYOPATHY 2 0.0001
668 INSOMNIA 36 0.0001
669 COLON CANCER 2 0.0001
670 IMMUNODEFICIENCY 2 0.0001
671 HAEMORRHAGE INTRACRANIAL 2 0.0001
672 HYPOAESTHESIA ORAL 2 0.0001
673 NEUTROPENIA 18 0.0001
674 APPLICATION SITE PRURITUS 3 0.0001
675 THERAPEUTIC RESPONSE DECREASED 8 0.0001
676 OSTEOPENIA 2 0.0001
677 INSURANCE ISSUE 2 0.0001
678 SKIN DISCOLOURATION 6 0.0001
679 MUSCLE TWITCHING 3 0.0001
680 DIARRHOEA 84 0.0001
681 LYMPHOMA 2 0.0001
682 ANKLE FRACTURE 2 0.0001
683 TENDONITIS 2 0.0001
684 LUNG INFECTION 2 0.0001
685 THERAPY PARTIAL RESPONDER 2 0.0001
686 BASAL CELL CARCINOMA 2 0.0001
687 BRAIN FOG 2 0.0001
688 AFFECTIVE DISORDER 1 0.0001
689 CYANOSIS 2 0.0001
690 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
691 SINUSITIS 13 0.0001
692 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
693 PREMATURE DELIVERY 2 0.0001
694 VOMITING 59 0.0001
695 SCIATICA 2 0.0001
696 DIABETIC KETOACIDOSIS 3 0.0001
697 ABDOMINAL PAIN 29 0.0001
698 NIGHT SWEATS 4 0.0001
699 LACTIC ACIDOSIS 4 0.0001
700 NEURALGIA 3 0.0001
701 ENCEPHALOPATHY 3 0.0001
702 PHOTOSENSITIVITY REACTION 2 0.0001
703 CYTOMEGALOVIRUS INFECTION 2 0.0001
704 COAGULOPATHY 2 0.0001
705 POLLAKIURIA 5 0.0001
706 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
707 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
708 CHEST PAIN 22 0.0001
709 HAEMATEMESIS 3 0.0001
710 WHEEZING 7 0.0001
711 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
712 FALL 39 0.0001
713 INFLUENZA 13 0.0001
714 VISION BLURRED 16 0.0001
715 MUSCULOSKELETAL DISCOMFORT 2 0.0001
716 SKIN ULCER 3 0.0001
717 PARANOIA 2 0.0001
718 PULMONARY EMBOLISM 11 0.0001
719 BALANCE DISORDER 10 0.0001
720 COUGH 32 0.0001
721 HYPOAESTHESIA 17 0.0001
722 ATRIAL FIBRILLATION 11 0.0001
723 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
724 ALOPECIA 22 0.0001
725 THIRST 2 0.0001
726 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
727 THERAPY NON-RESPONDER 5 0.0001
728 ANAL INCONTINENCE 1 0.0001
729 FREQUENT BOWEL MOVEMENTS 3 0.0001
730 SYNOVITIS 2 0.0001
731 GASTROENTERITIS VIRAL 2 0.0001
732 OSTEOMYELITIS 2 0.0001
733 SKIN IRRITATION 5 0.0001
734 HYPERTENSION 23 0.0001
735 COVID-19 19 0.0001
736 DIVERTICULITIS 3 0.0001
737 AGRANULOCYTOSIS 2 0.0001
738 URTICARIA 18 0.0001
739 COGNITIVE DISORDER 5 0.0001
740 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
741 ASTHMA 12 0.0001
742 FRACTURE 2 0.0001
743 ARRHYTHMIA 5 0.0001
744 OCULAR HYPERAEMIA 5 0.0001
745 DYSPHAGIA 10 0.0001
746 DISEASE RECURRENCE 5 0.0001
747 HERPES ZOSTER 6 0.0001
748 CONTUSION 10 0.0001
749 HERNIA 2 0.0001
750 PRESCRIBED OVERDOSE 2 0.0001
751 EAR PAIN 2 0.0001
752 DYSSTASIA 3 0.0001
753 MUSCULOSKELETAL STIFFNESS 9 0.0001
754 MALAISE 45 0.0001
755 MEMORY IMPAIRMENT 14 0.0001
756 DISABILITY 2 0.0001
757 HAEMATOCRIT DECREASED 2 0.0001
758 DYSPNOEA 57 0.0001
759 PRESCRIBED UNDERDOSE 2 0.0001
760 NAUSEA 79 0.0001
761 HEPATIC FAILURE 3 0.0001
762 FULL BLOOD COUNT DECREASED 2 0.0001
763 SLEEP DISORDER 7 0.0001
764 PRODUCT PHYSICAL ISSUE 2 0.0001
765 ILL-DEFINED DISORDER 6 0.0001
766 PSORIATIC ARTHROPATHY 4 0.0001
767 THROMBOCYTOPENIA 11 0.0001
768 PRODUCT PREPARATION ERROR 2 0.0001
769 RIB FRACTURE 2 0.0001
770 CARDIAC ARREST 8 0.0001
771 INFLAMMATION 5 0.0001
772 PERITONITIS 2 0.0001
773 ABDOMINAL DISTENSION 10 0.0001
774 INTENTIONAL DRUG MISUSE 2 0.0001
775 SPEECH DISORDER 5 0.0001
776 CONDITION AGGRAVATED 29 0.0001
777 RENAL FAILURE ACUTE 4 0.0001
778 DIZZINESS 47 0.0001
779 RETCHING 2 0.0001
780 MOVEMENT DISORDER 3 0.0001
781 IRRITABLE BOWEL SYNDROME 2 0.0001
782 WEIGHT DECREASED 26 0.0001
783 DISEASE PROGRESSION 11 0.0001
784 HYPOACUSIS 4 0.0001
785 RHINORRHOEA 6 0.0001
786 PRURITUS GENERALISED 2 0.0001
787 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
788 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
789 PERIPHERAL SWELLING 14 0.0001
790 PRODUCT USE ISSUE 17 0.0001
791 VISUAL ACUITY REDUCED 3 0.0001
792 ARTHROPATHY 5 0.0001
793 TOOTH DISORDER 2 0.0001
794 COLITIS ULCERATIVE 4 0.0001
795 NECK PAIN 5 0.0001
796 ORAL PAIN 2 0.0001
797 GASTROINTESTINAL DISORDER 8 0.0001
798 RASH PAPULAR 2 0.0001
799 THROAT IRRITATION 4 0.0001
800 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
801 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
802 FLUSHING 9 0.0001
803 GASTRIC DISORDER 3 0.0001
804 NIGHTMARE 3 0.0001
805 OROPHARYNGEAL PAIN 8 0.0001
806 NEOPLASM PROGRESSION 3 0.0001
807 BACK PAIN 20 0.0001
808 RENAL DISORDER 4 0.0001
809 RASH MACULAR 3 0.0001
810 BLOOD CHOLESTEROL INCREASED 4 0.0001
811 SWELLING 8 0.0001
812 INJURY 6 0.0001
813 ASTHENIA 32 0.0001
814 HYPOTENSION 17 0.0001
815 PRODUCTIVE COUGH 4 0.0001
816 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
817 MENTAL IMPAIRMENT 2 0.0001
818 PRESYNCOPE 2 0.0001
819 OFF LABEL USE 72 0.0001
820 VERTIGO 5 0.0001
821 DRUG INTERACTION 13 0.0001
822 LIVER INJURY 2 0.0001
823 HEADACHE 51 0.0001
824 ABNORMAL WEIGHT GAIN 1 0.0001
825 OSTEONECROSIS OF JAW 2 0.0001
826 AGEUSIA 2 0.0001
827 HALLUCINATION 6 0.0001
828 DEPRESSION 18 0.0001
829 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
830 INJECTION SITE SWELLING 6 0.0001
831 HEPATITIS 2 0.0001
832 SEIZURE 9 0.0001
833 DRUG RESISTANCE 2 0.0001
834 ANAPHYLACTIC SHOCK 2 0.0001
835 UNRESPONSIVE TO STIMULI 2 0.0001
836 HAEMATOMA 2 0.0001
837 DIPLOPIA 2 0.0001
838 MUCOSAL INFLAMMATION 2 0.0001
839 JOINT STIFFNESS 2 0.0001
840 ANHEDONIA 2 0.0001
841 INFECTION 11 0.0001
842 ABNORMAL BEHAVIOUR 3 0.0001
843 PANCREATITIS 4 0.0001
844 THROMBOSIS 6 0.0001
845 ARTHRALGIA 31 0.0001
846 SOMNOLENCE 15 0.0001
847 JAUNDICE 2 0.0001
848 DISTURBANCE IN ATTENTION 4 0.0001
849 DYSKINESIA 3 0.0001
850 PALLOR 2 0.0001
851 HEPATIC ENZYME INCREASED 5 0.0001
852 PAIN 45 0.0001
853 TREATMENT NONCOMPLIANCE 4 0.0001
854 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
855 SKIN LESION 2 0.0001
856 APPLICATION SITE RASH 1 0.0001
857 INJECTION SITE REACTION 5 0.0001
858 RESPIRATORY ARREST 2 0.0001
859 ABNORMAL DREAMS 2 0.0001
860 TREMOR 12 0.0001
861 RHABDOMYOLYSIS 3 0.0001
862 FEELING COLD 2 0.0001
863 ROAD TRAFFIC ACCIDENT 3 0.0001
864 ABDOMINAL DISCOMFORT 12 0.0001
865 LOSS OF CONSCIOUSNESS 9 0.0001
866 ANOSMIA 1 0.0001
867 DEVICE DISLOCATION 3 0.0001
868 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
869 BONE PAIN 4 0.0001
870 BLADDER CANCER 4 0.0001
871 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
872 URINARY INCONTINENCE 2 0.0001
873 HAEMORRHAGE 7 0.0001
874 PREMATURE BABY 2 0.0001
875 APHASIA 2 0.0001
876 LACRIMATION INCREASED 2 0.0001
877 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
878 CHRONIC KIDNEY DISEASE 5 0.0001
879 INJECTION SITE RASH 2 0.0001
880 MYALGIA 11 0.0001
881 PRODUCT DOSE OMISSION ISSUE 19 0.0001
882 VISUAL IMPAIRMENT 8 0.0001
883 PAIN IN EXTREMITY 19 0.0001
884 EXPOSURE DURING PREGNANCY 4 0.0001
885 NERVOUS SYSTEM DISORDER 2 0.0001
886 SWOLLEN TONGUE 2 0.0001
887 MOOD SWINGS 2 0.0001
888 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
889 CARDIAC FAILURE CONGESTIVE 5 0.0001
890 HIP FRACTURE 2 0.0001
891 CONFUSIONAL STATE 10 0.0001
892 AMNESIA 4 0.0001
893 SWELLING FACE 4 0.0001
894 PSORIASIS 8 0.0001
895 LUNG DISORDER 3 0.0001
896 HEART RATE INCREASED 6 0.0001
897 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
898 SYNCOPE 6 0.0001
899 MUSCLE SPASMS 11 0.0001
900 GAIT INABILITY 2 0.0001
901 PALPITATIONS 7 0.0001
902 CHILLS 7 0.0001
903 FLUID RETENTION 3 0.0001
904 FEELING ABNORMAL 14 0.0001
905 WEIGHT INCREASED 13 0.0001
906 JOINT SWELLING 7 0.0001
907 INTENTIONAL PRODUCT MISUSE 5 0.0001
908 DEPRESSED MOOD 3 0.0001
909 FATIGUE 44 0.0001
910 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
911 INJECTION SITE ERYTHEMA 7 0.0001
912 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
913 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
914 INJECTION SITE PAIN 17 0.0001
915 RASH PRURITIC 3 0.0001
916 HYPERSENSITIVITY 10 0.0001
917 DYSGEUSIA 4 0.0001
918 CARDIAC DISORDER 5 0.0001
919 ABDOMINAL PAIN UPPER 11 0.0001
920 CEREBROVASCULAR ACCIDENT 9 0.0001
921 BLOOD GLUCOSE INCREASED 10 0.0001
922 ACNE 4 0.0001
923 MIGRAINE 5 0.0001
924 LETHARGY 3 0.0001
925 PRODUCT SUBSTITUTION ISSUE 3 0.0001
926 HOSPITALISATION 8 0.0001
927 DYSPHONIA 3 0.0001
928 PLASMA CELL MYELOMA 2 0.0001
929 DISORIENTATION 2 0.0001
930 DRY MOUTH 4 0.0000
931 ANXIETY 14 0.0000
932 BLINDNESS 2 0.0000
933 OSTEOPOROSIS 2 0.0000
934 ILLNESS 5 0.0000
935 INCORRECT DOSE ADMINISTERED 11 0.0000
936 CARDIO-RESPIRATORY ARREST 2 0.0000
937 GAIT DISTURBANCE 9 0.0000
938 DEATH 40 0.0000
939 MENTAL DISORDER 2 0.0000
940 MYOCARDIAL INFARCTION 8 0.0000
941 DRUG INEFFECTIVE 60 0.0000
942 DEVICE ISSUE 4 0.0000
943 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
944 PARAESTHESIA 7 0.0000
945 RHEUMATOID ARTHRITIS 5 0.0000
946 NEPHROLITHIASIS 2 0.0000
947 TINNITUS 2 0.0000
948 BREAST CANCER 4 0.0000
949 BURNING SENSATION 3 0.0000
950 COMA 2 0.0000
951 SKIN BURNING SENSATION 3 0.0000
952 MOBILITY DECREASED 3 0.0000
953 OVERDOSE 9 0.0000
954 BLOOD GLUCOSE DECREASED 2 0.0000
955 UNDERDOSE 3 0.0000
956 ABASIA 1 0.0000
957 HOT FLUSH 3 0.0000
958 BLOOD PRESSURE INCREASED 6 0.0000
959 CHEST DISCOMFORT 4 0.0000
960 HYPERHIDROSIS 5 0.0000
961 ARTHRITIS 3 0.0000
962 INJECTION SITE BRUISING 3 0.0000
963 PROSTATE CANCER 3 0.0000
964 ANAPHYLACTIC REACTION 2 0.0000
965 MEDICATION ERROR 2 0.0000
966 FLATULENCE 2 0.0000
967 CONVULSION 2 0.0000
968 EYE IRRITATION 2 0.0000
969 IRRITABILITY 2 0.0000
970 EMOTIONAL DISTRESS 4 0.0000
971 SUICIDAL IDEATION 3 0.0000
972 ADVERSE EVENT 3 0.0000
973 DRUG INTOLERANCE 3 0.0000
974 PRODUCT DOSE OMISSION 2 0.0000
975 INJECTION SITE PRURITUS 2 0.0000
976 TOXICITY TO VARIOUS AGENTS 5 0.0000
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
978 ACCIDENTAL OVERDOSE 1 0.0000
979 AGITATION 2 0.0000
980 UNEVALUABLE EVENT 2 0.0000
981 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
982 INFLUENZA LIKE ILLNESS 2 0.0000
983 DRUG DOSE OMISSION 4 0.0000
984 TREATMENT FAILURE 2 0.0000
985 DRUG ABUSE 2 0.0000
986 DRUG WITHDRAWAL SYNDROME 2 0.0000
987 ANGIOEDEMA 1 0.0000
988 ADVERSE DRUG REACTION 2 0.0000
989 PRODUCT QUALITY ISSUE 3 0.0000
990 NO ADVERSE EVENT 4 0.0000